Everest Organics Ltd. (EVERESTO): Everest Organics Share Price rises 11.81% today to Rs 267.85

Published: 25 September 2026 at 9:49:53 AM IST

Everest Organics Ltd. (EVERESTO) rose 11.81% to Rs 267.85 today, with market capitalisation at Rs 238.92 Cr and turnover of Rs 0.01 Cr.

Everest Organics Share Price rose sharply today, with the stock closing at Rs 267.85 after an 11.81% move from the previous close of Rs 239.55. The company’s market capitalisation stands at Rs 238.92 Cr, placing the latest share price rise in a clearly defined financial context for Everest Organics Ltd. The day’s range extended from Rs 239 to Rs 267.85, while turnover stood at Rs 0.01 Cr. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers following Everest Organics Share Price Today, the important point is that the stock has moved decisively higher in a single session, making Everest Organics Stock News relevant for both price-action watchers and fundamental investors.

In this Everest Organics Share Price article, Univest looks at what changed today, how the valuation compares with the pharmaceuticals peer set, and whether the company’s earnings and return ratios add context to the move. The stock’s rise is notable because the current valuation sits alongside negative ROE and modest ROCE, which means the latest price action should be read together with the wider Everest Organics Stock Analysis and Everest Organics Fundamental Analysis rather than in isolation.

Everest Organics Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 267.85
Previous Close	Rs 239.55
Today's Move	Rs 28.3 (+11.81%)
Open	Rs 241.95
High	Rs 267.85
Low	Rs 239
Turnover	Rs 0.01 crore
Market Capitalisation	Rs 238.92 crore
Market Cap Category	Micro Cap

Everest Organics Ltd. (EVERESTO) rose to Rs 267.85 from the previous close of Rs 239.55, a move of Rs 28.3 or 11.81%. The stock opened at Rs 241.95, reached a high of Rs 267.85, recorded a low of Rs 239.

Everest Organics Share Price Today showed a clear same-day price rise from Rs 239.55 to Rs 267.85. The stock opened at Rs 241.95, touched a low of Rs 239 and a high of Rs 267.85, and finished at the session high. The absolute move was Rs 28.30, or 11.81%, which makes Everest Organics one of the more notable Stocks in News within the healthcare space today. The data also shows turnover of Rs 0.01 Cr, which is a factual traded-value figure and should be read alongside the day’s price action. As always, Univest presents the verified move without assigning a cause that is not supported by the supplied data.

Everest Organics Ltd. (EVERESTO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 238.92 crore
P/E Ratio	45.47x
P/B Ratio	2.96x
ROE	-2.25%
ROCE	1.76%
EPS	Rs 5.27
Book Value Per Share	Rs 80.8
Dividend Yield	0%

Everest Organics Ltd. (EVERESTO) fundamental metrics show P/E 45.47x, P/B 2.96x, ROE -2.25%, ROCE 1.76%. These figures provide context only and are not a buy or sell signal.

Everest Organics Ltd. has a market capitalisation of Rs 238.92 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 45.47x, P/B at 2.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -2.25% and ROCE of 1.76%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 5.27, book value per share of Rs 80.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	45.47x
Benchmark Median P/E	32.73x
Benchmark Average P/E	49.58x
Benchmark P/E Range	3.48x to 757.76x
Company P/B Ratio	2.96x
Benchmark Median P/B	2.95x
Company ROE	-2.25%
Benchmark Median ROE	11.7%
Company ROCE	1.76%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 238.92 crore
Benchmark Median Market Cap	Rs 804.62 crore

Everest Organics Ltd. (EVERESTO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Everest Organics Ltd. (EVERESTO) has a P/E ratio of 45.47x, which is above the benchmark median of 32.73x, a difference of +38.92%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Everest Organics Ltd. (EVERESTO) has a ROE of -2.25%, which is below the benchmark median of 11.7%, a difference of -119.23%. Everest Organics Ltd. (EVERESTO) has a ROCE of 1.76%, which is below the benchmark median of 13.61%, a difference of -87.07%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,47,475.97	36.76	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,54,763.56	87.25	14.45	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,423.19	86.07	20.91	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,16,658.07	26.08	4.37	19.69	21.39
Cipla Ltd.	CIPLA	1,11,484.47	33.65	3.23	11.83	16

Everest Organics Ltd. (EVERESTO) has a P/E ratio of 45.47x compared with the displayed peer median of 36.76x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.25% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Everest Organics Ltd. (EVERESTO) has a market capitalisation of Rs 238.92 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Everest Organics

• Everest Organics Share Price rose 11.81% today to Rs 267.85, after closing above the previous close of Rs 239.55.
• The stock’s market capitalisation stands at Rs 238.92 Cr, giving Everest Organics a defined small-company valuation base in this dataset.
• The P/E ratio is 45.47, above the same-industry median of 32.73 and below the industry average of 49.58.
• ROE is -2.25 and ROCE is 1.76, both below the healthcare industry medians shown in the sector snapshot.
• The company trades on a P/B of 2.96, nearly in line with the industry median P/B of 2.95.

About Everest Organics

Everest Organics Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its market metrics rather than a detailed business segment breakdown, so the focus here is on the verified operating context. Everest Organics is part of a broad pharmaceutical peer group that includes large diversified drug makers, specialty names and formulation-focused companies. That matters because Everest Organics Share Price is being judged in the same industry frame as Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. The company’s current valuation, profitability and market capitalisation indicate a smaller presence within the sector, but the latest Everest Organics Stock News shows that even a modest market-cap name can record a meaningful same-day price rise. Readers following Everest Organics Share Price Today can use this context to connect the daily move with the company’s place in the wider pharmaceutical set.

Track Everest Organics Share Price on Univest

Use Everest Organics Ltd. (EVERESTO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Everest Organics Share Price on Univest for live share price updates, company fundamentals, valuation ratios, shareholding pattern, 52-week levels and market insights. Univest brings the latest Everest Organics Stock News, Everest Organics Share News and Everest Organics Share Price Update into one place so readers can follow the stock with the same verified data used in this article.

Frequently Asked Questions

Why did Everest Organics Share Price rise today?

Ans. The supplied data confirms an 11.81% same-day rise in Everest Organics Share Price to Rs 267.85, but it does not establish a company-specific catalyst. The move is verified through price, open, high, low and turnover figures.

What is Everest Organics Share Price today?

Ans. Everest Organics Share Price today is Rs 267.85. The stock moved up Rs 28.30 from the previous close of Rs 239.55, and the session high matched the closing level. The previous close was Rs 239.55.

What is Everest Organics market capitalisation now?

Ans. Everest Organics market capitalisation is Rs 238.92 Cr. That places the company below the industry median market cap in the supplied pharmaceutical benchmark and gives useful size context for Everest Organics Share Price.

How does Everest Organics compare on valuation?

Ans. Everest Organics has a P/E of 45.47 and a P/B of 2.96. The P/E sits above the industry median of 32.73, while the P/B is almost identical to the industry median of 2.95.

What do Everest Organics EPS and book value show?

Ans. EPS is 5.27 and book value is Rs 80.8 per share. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share behind Everest Organics Share Price.

How strong are Everest Organics profitability ratios?

Ans. Everest Organics reports ROE of -2.25 and ROCE of 1.76. Both are below the healthcare industry medians in the sector snapshot, so profitability remains an important context for Everest Organics Share Price.

Which sector and industry does Everest Organics belong to?

Ans. Everest Organics belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That is the correct benchmark set for comparing Everest Organics Share Price with peers and broader industry valuation.

How does Everest Organics compare with listed peers?

Ans. Compared with Sun Pharma, Divi’s Labs, Torrent Pharma, Zydus Lifesciences and Cipla, Everest Organics is much smaller on market capitalisation and has weaker return ratios. That frames the stock’s latest move in a clear peer context.